Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
American Journal of Human Genetics
|
July 1, 1993
Genetic heterogeneity in families with hereditary multiple exostoses
A Cook, W Raskind, S H Blanton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging
Joseph G Rajendran, David A Mankoff, Finbarr O'Sullivan, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
June 9, 2004
Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro
Howard A Chansky, Fariba Barahmand-Pour, Qi Mei, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2020
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy
Brett A Schroeder, Ralph Graeme Black, Sydney Spadinger, et al.
Plos One
|
March 3, 2012
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine
Seth M Pollack, Yonqing Li, Megan J Blaisdell, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 13, 2003
[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression
J G Rajendran, D C Wilson, E U Conrad, et al.
Cancer
|
February 24, 2012
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma
Seth M Pollack, Achim A Jungbluth, Benjamin L Hoch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study
J S Wunder, S B Bull, V Aneliunas, et al.
Cancer
|
July 29, 2009
Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group
Alexander J Chou, Eugenie S Kleinerman, Mark D Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2005
TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study
Jay S Wunder, Nalan Gokgoz, Robert Parkes, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
American Journal of Human Genetics
|
July 1, 1993
Genetic heterogeneity in families with hereditary multiple exostoses
A Cook, W Raskind, S H Blanton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging
Joseph G Rajendran, David A Mankoff, Finbarr O'Sullivan, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
June 9, 2004
Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro
Howard A Chansky, Fariba Barahmand-Pour, Qi Mei, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2020
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy
Brett A Schroeder, Ralph Graeme Black, Sydney Spadinger, et al.
Plos One
|
March 3, 2012
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine
Seth M Pollack, Yonqing Li, Megan J Blaisdell, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 13, 2003
[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression
J G Rajendran, D C Wilson, E U Conrad, et al.
Cancer
|
February 24, 2012
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma
Seth M Pollack, Achim A Jungbluth, Benjamin L Hoch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study
J S Wunder, S B Bull, V Aneliunas, et al.
Cancer
|
July 29, 2009
Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group
Alexander J Chou, Eugenie S Kleinerman, Mark D Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2005
TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study
Jay S Wunder, Nalan Gokgoz, Robert Parkes, et al.
Page
of 12